📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
44 announcements match the current filters (relevance ≥ 5).
Max Healthcare Q3 PAT Rises 26% YoY to ₹301 Cr; Dwarka Hospital Expansion Approved
Max Healthcare Institute reported a steady performance for Q3 FY26 with consolidated revenue growing 10.7% YoY to ₹2,067.5 crore. Net profit (PAT) saw a robust 26% YoY increase to ₹300.9 crore, despite an exceptional charge of ₹48.2 crore during the quarter. The company is aggressively pursuing growth, evidenced by the board's approval to add ~260 beds to its Dwarka facility, nearly doubling its current 300-bed capacity. While sequential (QoQ) performance showed a slight dip in revenue and profit, the nine-month PAT growth of 45% YoY highlights strong operational momentum.
Key Highlights
Consolidated Revenue from operations increased 10.7% YoY to ₹2,06,752 Lakhs.
Net Profit (PAT) for the quarter rose 26% YoY to ₹30,092 Lakhs from ₹23,880 Lakhs.
Board approved expansion of Max Super Speciality Hospital, Dwarka by adding ~260 additional beds.
Nine-month (9M FY26) PAT reached ₹1,10,019 Lakhs, a 45% increase over the previous year's ₹75,688 Lakhs.
Exceptional item of ₹4,824 Lakhs recorded in Q3 FY26, impacting the pre-tax profit.
👀 What to Watch
Investors should remain positive on the stock given the strong YoY earnings growth and the clear roadmap for capacity expansion in high-demand areas like Dwarka. The long-term outlook remains healthy as the company scales its bed capacity and maintains double-digit revenue growth.
Max Healthcare to Invest INR 1000 Cr+ for New 450-Bed Hospital in Pune
Max Healthcare has announced its entry into the Pune market through the staggered acquisition of 100% equity in Yerawada Properties Private Limited. The company plans to develop a 450-bed super-specialty hospital with a total investment exceeding INR 1,000 crore. Located in the prime Yerawada area, the facility is expected to be commissioned within the next three years. This strategic move marks the company's fourth facility in Western India and aligns with its vision to capture high-growth urban healthcare markets.
Key Highlights
Total investment of over INR 1,000 crore for a 450-bed super-specialty hospital in Pune
Staggered acquisition of 100% equity stake in Yerawada Properties Private Limited (YPPL)
Facility expected to be commissioned over the next 3 years in the prime Yerawada locality
Marks the company's 4th facility in Western India, strengthening its Maharashtra presence
👀 What to Watch
Investors should monitor the project's execution timeline and capital allocation efficiency over the next three years. The expansion into a high-demand urban market like Pune is a strong long-term growth driver for the company's portfolio.
Max Healthcare to Invest ₹1,020 Cr for New 450-Bed Hospital in Pune via YPPL Acquisition
Max Healthcare has approved the acquisition of a 100% equity stake in Yerawada Properties Private Limited (YPPL) to establish a new ~450-bed super speciality hospital in Pune. The total investment for this project is estimated at ₹1,020 crore, which includes the ₹200 crore acquisition cost, construction, and equipment. This strategic move aims to expand the company's footprint in Maharashtra, addressing high demand as its current network operates at over 76% capacity utilization. The project will be funded through a mix of internal accruals and debt, with a completion timeline of approximately four years.
Key Highlights
Acquisition of 100% equity in YPPL for ~₹200 crore to secure 1.68 acres of prime land in Pune.
Total capital expenditure of ₹1,020 crore planned for a new ~450-bed super speciality hospital.
Project completion and capacity addition expected over a period of approximately 4 years.
Strategic entry into the Pune market to leverage high existing network utilization of >76%.
Funding to be sourced through a combination of internal accruals and term loans.
👀 What to Watch
This expansion is a strong long-term growth catalyst that diversifies Max Healthcare's geographic presence into the high-demand Pune market. Investors should view this as a positive development for future revenue scaling, though the four-year gestation period requires a long-term investment horizon.
Max Healthcare to Invest ₹1,020 Cr for New 450-Bed Hospital in Pune via YPPL Acquisition
Max Healthcare has approved the acquisition of Yerawada Properties Private Limited (YPPL) to facilitate the development of a new ~450-bed super speciality hospital in Pune. The total project investment is estimated at ₹1,020 Crore, which includes ~₹200 Crore for the 100% equity acquisition of YPPL and the remaining for construction and equipment. This move is aimed at addressing high capacity utilization across the existing network, which exceeded 76% in H1 FY26. The project will be funded through a mix of internal accruals and debt, with a completion timeline of approximately 4 years.
Key Highlights
Total investment of ₹1,020 Crore for a new ~450-bed super speciality hospital in Pune.
Acquisition of 100% equity in Yerawada Properties (YPPL) for ~₹200 Crore to secure 1.68 acres of land.
Project to be completed in a phased manner over an indicative timeline of 4 years.
Existing network capacity utilization is high at >76% as of H1 FY26, necessitating expansion.
Funding strategy involves a combination of internal accruals and term loans.
👀 What to Watch
Investors should view this as a significant long-term growth catalyst that strengthens Max Healthcare's presence in the high-demand Maharashtra market. Monitor the company's debt-to-equity ratio as it takes on term loans for this large-scale capital expenditure.
